{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:26:44Z","timestamp":1790638004934,"version":"4.1.0"},"reference-count":24,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s273287","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T23:45:51Z","timestamp":1603928751000},"page":"2539-2551","source":"Crossref","is-referenced-by-count":15,"title":["<p>Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression<\/p>"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-4821","authenticated-orcid":true,"given":"Joanna","family":"Szarmach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-8454","authenticated-orcid":true,"given":"Wies\u0142aw Jerzy","family":"Cuba\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8549-254X","authenticated-orcid":true,"given":"Adam","family":"W\u0142odarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-614X","authenticated-orcid":true,"given":"Maria","family":"Ga\u0142uszko-W\u0119gielnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0006-3223(99)00230-9","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S135623","author":"Correia-Melo","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011611.pub2","author":"McCloud","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","author":"Szarmach","year":"2019","journal-title":"Psychiatr Danub"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Fedgchin M, Trivedi M, Daly EJ, et al. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).\u00a0Int J Neuropsychopharmacol. 2019;22(10):616\u2013630. doi:10.1093\/ijnp\/pyz039","DOI":"10.1093\/ijnp\/pyz039"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1213\/00000539-196811000-00025","volume":"47","author":"Traber","year":"1968","journal-title":"Anesth Analg"},{"key":"ref9","volume-title":"Miller\u2019s Anesthesia","year":"2015"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jad.2018.02.025","volume":"236","author":"Riva-Posse","year":"2018","journal-title":"J Afect Disord"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4088\/JCP.13m08852","volume":"76","author":"Wan","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/1570159X13666150630171954","volume":"13","author":"Poon","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1755-5949.2009.00102.x","volume":"16","author":"Chandler","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/YIC.0b013e3283277614","volume":"24","author":"Trivedi","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"ref15","first-page":"87","volume":"29","author":"Young","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jad.2020.06.020","volume":"275","author":"Zheng","year":"2020","journal-title":"J Affect Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","volume":"176","author":"Popova","year":"2019","journal-title":"Am J Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40263-020-00699-4","volume":"34","author":"Doherty","year":"2020","journal-title":"CNS Drugs"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e79, 1","DOI":"10.1017\/S2045796019000751","volume":"29","author":"Gastaldon","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jad.2019.10.050","volume":"262","author":"Lu","year":"2020","journal-title":"J Affect Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.03.020","volume":"127","author":"Peyrovian","year":"2020","journal-title":"J Psychiatr Res"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=63076","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=63076","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T23:45:53Z","timestamp":1603928753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/metabolic-risk-factors-and-cardiovascular-safety-in-ketamine-use-for-t-peer-reviewed-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2147\/ndt.s273287","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}